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Not until the nineteenth century was it generally agreed 
that arteries and veins are connected by capillaries and 
that these capillaries indeed have a cellular wall, the so-
called endothelium. At this point in time, one was con-
vinced that the endothelium was a passive inner layer of 
blood vessels, not participating in any kind of active 
processes. Nowadays, better understanding of physio  lo-
gical processes involving the endothelium (for example, 
coagulation, hemostasis, and so forth) has led to 
appreciation of the endothelium as in independent and 
active organ system. During the past decade, endothelial 
injury has attracted much attention – being a crucial 
event in the pathogenesis of experimental septic organ 
dysfunction. As a consequence, several circulating factors 
released by the activated endothelial cells, neighboring 
support cells (such as vascular smooth muscle cells and 
pericytes), or platelets have been identiﬁ  ed as biomarkers 
of outcome in sepsis.
In the previous issue of Critical Care, Mankhambo and 
colleagues report on circulating levels of vascular endo-
thelial growth factor (VEGF), platelet-derived growth 
factor, ﬁ  broblast growth factor, angiopoietin (Ang)-1 and 
Ang-2 in Malawian children with severe infection [1]. 
Th  ey found robust increases in VEGF, platelet-derived 
growth factor, ﬁ  broblast growth factor and Ang-2 levels 
(twofold to ninefold), whereas Ang-1 was modestly 
decreased by only 15% (not signiﬁ  cant). Survivors had 
lower Ang-2 and higher platelet-derived growth factor 
and Ang-1 levels, respectively (Figure 1). Only (low) 
Ang-1, however, was signiﬁ  cantly associated with mor-
tality after multivariate adjustment.
In 1996 the Ang/Tie2 ligand-receptor system was dis-
covered as the second class of vascular-speciﬁ  c receptor 
tyrosine kinases (the ﬁ   rst being the VEGF/VEGF-
receptor system). Classically thought of as an important 
regulator in vessel maturation and remodeling, recent 
studies demonstrated that the Ang/Tie2 system not only 
regulates angiogenesis but also controls endothelial 
inﬂ  am  mation in a nonredundant manner [2]. Ang-1 and 
Ang-2 are antagonistic ligands that bind to the 
extracellular domain of the Tie2 receptor, which is almost 
exclusively expressed by endothelial cells. Binding of the 
agonist Ang-1 maintains vessel integrity, inhibits vascular 
leakage, suppresses inﬂ  ammatory gene expression, and 
prevents recruitment and transmigration of leukocytes 
[3]. In contrast, binding of Ang-2 to Tie2 disrupts protec-
tive Ang-1 signaling and facilitates endothelial inﬂ  amma-
tion, most probably via preventing Ang-1 from 
phosphorylating Tie2 [4]. Ang-2 was identiﬁ  ed recently as 
a strong and independent predictor of outcome in early 
and later stages of critical illness in adults [5-9].
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sepsis are still very limited. Giuliano and coworkers were 
the ﬁ  rst to report that Ang-2 levels were signiﬁ  cantly 
elevated and Ang-1 levels were signiﬁ  cantly decreased in 
children with septic shock compared to children with 
either systemic inﬂ   ammatory response syndrome or 
sepsis [10]. Only circulating Ang-2, however, correlated 
with disease severity and outcome. Th  e  same 
investigators analyzed Ang-2 release in children after 
cardiopulmonary bypass surgery [11]. Th  ey identiﬁ  ed a 
close correlation of Ang-2 with surrogate markers of 
capillary leakage and found a relevant role of Ang-2 in 
predicting the intensive care unit length of stay. In 
contrast to septic children of the aforementioned study, 
circulating Ang-1 levels were normal or even elevated 
after cardiopulmonary bypass. Finally, recent data com-
ing from Ugandan children indi  cate that Ang-2 might 
serve as a biomarker to discrimi  nate uncompli  cated 
malaria from cerebral malaria [12].
While the mediator function of both Ang-1 and Ang-2 
has been well established in preclinical research, only 
Ang-2 has been established as a clinically useful 
biomarker in the critical care arena [13]. Speculation is 
tempting, however, on the disturbances in the Ang/Tie2 
system during sepsis being a shift from the more 
protective Ang-1 to the more vascular disruptive Ang-2 
[13]. While some authors found elevated Ang-1 levels, 
others detected low Ang-1 concentrations in intensive 
care unit patients. Th  is ﬁ  nding might be explained by 
diﬀ   erences in the samples used for analysis. Unlike 
Ang-2, which is exclusively stored in endothelial cells, 
Ang-1 is not exclusively expressed by the vascular wall 
(Figure 1) – a high amount of Ang-1 (and VEGF) is also 
found in platelets [14]. False positive Ang-1 levels can 
Figure 1. Schematic model of circulating levels of angiogenic factors in Malawian children with severe infection. Schematic model of the 
main fi  ndings for circulating levels of vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), fi  broblast growth factor 
(FGF), angiopoietin (Ang)-1 and Ang-2 in Malawian children with severe infection from the study by Mankhambo and colleagues [1]. CI, confi  dence 
interval; OR, odds ratio.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx  xx
Subendothelial
extracell. Matrix
xxxxxxxxxxxxxxxx xxxxxxxxxx x x x x x x x xx xx xx x x xx x xxx x xx xx x xx x xx xxxx x xx xx xx x xx xx xx x x xx x xx xx xx xx xx xxx xx xx x xx xx x xxxx xx xx xx xx xx xxxxxxxxx xxx x x x xx xx xx xx x xx xx x x xx x x x xxx xx x x xx x x xxx xx x xxxx xxxx xx x x xxx x xx x xx x xx xx xxxxx xxxxxx xxxxxx xx xx xx x xx x x x x x x x x x x x xxxx xxx x x x x x xxxx x xxxx x xx xx xx xxxx xx x xx xx xxxx xx xx xx x xx xxx x x x x x x x x xx xx x xx x xx x x x x xx x x x x x x x x x xx x x x x x x x x x x xxx xx x xx xx xxxxxx x xx xx x xx x xx xx xxx xx x xx xxxx xx xx xx x xx xx xx x xxxx x xx xxxx xx xxxx xx xx xx x x x x x x x xxx xx x xx x x xxxx xx xx x xxxx x xx x x x xx xxx x x xx xx xx x x x x x xx xxx xx xxxx xx x xxx x x x x x xxx x xx x xx xx x xx x x x x x x xx x x xx xx xx x x xxx x xx x xx x xx xx xx x x x x x xx x x xx xx x xx xx x x xx x xx x xx x x xx x x xx x xx xx x x x x x x x x x x xx xx x x xx x x xx x x xx x x x x
Blood vessel
Healthy state
x xxx x xx xxx xx xx xx xxxx xx x xx xxx x x x xx xx xx xxxx xx xx xx xx xxx x x x xxx xx xx x xxxx xxxx x xxx x xx xx xx x xx xx xxxx xx xx xx xxx xx xx x xx xxxx x xx xxx xx xx x xx x x x xx x x x x x xxx xx x xx xxx x x x xx x xxx x xx x x xx x x xx x xx xx x x xx xx xx xxxxxxx xxxxxxx xxx xx xx xx x xx xxxxxx x x x x x x xxx xx xx xx xx xx xxxx xx xx x x x xxxxx x xx xx xx xxxxxxxxx xxxxx x xxx xx xx x x x x xx x x xx xx x x xx xx xx xx
!"#$%
&'()*%
!"#$% %
&'()*% Pericytes
$% #$ FGF
PDGF
Ang-1 
15 % 
Ang-2 (3x) 
VEGF (9x) 
PDGF (7x) 
FGF (2x) 
Ang-2
Endothelium
x x x xx xx xx xx x x x x x x x xx x xx x xxxx xxxx xxxx x xx xx x x xx x x xx x x xxx x x x x x x xx x x x x x x x x x x x x x xx x xx x x x x x x xx xx xx xx xx x xx x xx x xx x xx x x x x xx xx x x
PDGF
Platelets
Ang-1
VEGF
Sepsis
Ang-1
VEGF
Only adjusted Ang-1 predicted outcome (OR 0.23, 95% CI 0.08-0.69) 
GF
xx xx xx x x xxx xx x xx xxxx xx xx x x x x x x xx xx x xx x xx x x xx xx xx xx xx xx x xx xx x x x x x x xx xx x x xxx x x x x x x x x x x x xx x xx x x x xxxx x x xx xxxx xx xx xx x xx xx xx x xx xx x x x xx xx x xxx x xx x x x xx x xx x xx x x x x xx x xx xxxx x xx x xx xx x x xx xx x xx x xx x x x x x x xx xx xxxx xx xx xxx x x x xx xx xx xx xxxx xx xx x xxx x x xx x xx xx xx x xx xx xx x x x x x x x x x x xx x x x xx x x x x xx x x xx x x x xx xx x xx xx x xx xx xxx x x x x x xx xx x x x x xx xx xx xxx x x x x x x
xxxxxxxxxxxxxx  x x x x xx x x x x xx x x x xx x x x xx x x x xx x x xx x x xx x x x xx x x x x x x x x xx x x x x xx x x x xx x x xx x x x xx x x x x  x  x x x x x x x xx x x x x x xx x x x x x x xx x x x x xx x x x x x xx x x x x x xx x x x x x xx x x x x x xx x x x x x x x x xx x x x x xx x xx x x x xx x x x xx x x x x
David et al. Critical Care 2010, 14:180 
http://ccforum.com/content/14/4/180
Page 2 of 3therefore result from the ex vivo activation of platelets 
within serum tubes, a problem recognized only recently.
Th   e article by Mankhambo and colleagues adds know-
ledge to our current understanding of Ang-1 in critical 
illness. Plasma Ang-1 levels were not diﬀ  erent between 
patients and controls, but low Ang-1 was independently 
associated with poor prognosis. Th   erefore it is reasonable 
to assume that a very small decrease in circulating Ang-1 
has a huge impact on outcome, and that low Ang-1 is 
probably not associated with mortality in a linear fashion. 
One might speculate that low Ang-1 per se represents an 
important risk factor for adverse out  come in children 
with sepsis. Unfortunately, the authors neither investi-
gated the correlation between plasma Ang-1 and clinico-
pathologic features of multiorgan dys  func  tion syndrome, 
nor reported the sensitivity and speciﬁ   city of speciﬁ  c 
Ang-1 cut-oﬀ   values in predicting outcome.
With regard to the value of circulating Ang-1 as a 
biomarker in sepsis, several questions remain open. 
What is the role of Ang-1 in platelets and does platelet-
derived Ang-1 correlate with outcome? Is it possible to 
quantify Ang-1 in a compartment-speciﬁ  c fashion (that 
is, true circulating Ang-1 vs. platelet-derived Ang-1)? Is 
there a speciﬁ  c all-or-nothing cut-oﬀ   value for Ang-1, or 
is the ratio between Ang-1 and Ang-2 critical for out-
come prediction? All of these questions remain an active 
focus in several laboratories, including our own.
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